Journal of Immunology Research

Research Article

Proatherogenic Oxidized Low-Density Lipoprotein/2-Glycoprotein I Complexes in Arterial and Venous Disease

Table 1

Demographic and clinical characteristics of 100 study subjects by vascular disease phenotype.
 Controls 
() 		Arterial* 
() 		Venous 
() 		value**
Age (yrs, mean ± SD) 35.4 ± 12.5 71.0 ± 11.6 54.2 ± 12.4 <0.0001
Sex (F/M) 34 F/14 M 9 F/18 M 16 F/9 M 0.005
Smoking (%) 17.0 8.3 8.0 0.422
DM (%) 0 22.2 0 0.0002
High cholesterol (%)14.6 62.9 24.0 <0.0001
HTN (%) 8.3 55.6 24.0 <0.0001
BMI (kg/m2, mean ± SD) 26.3 ± 6.3 27.7 ± 5.7 30.1 ± 5.8 0.005
Fam Hx BC (%) 2.1 7.7 0 0.240
Fam Hx MI (%) 14.6 25.9 16.0 0.450
Fam Hx stroke (%) 4.2 7.4 0 0.394
Arterial disease = CarAD, PAD, AAA.
**Wilcoxon/Kruskal-Wallis Rank Sum or Pearson’s Chi-square.